SAN DIEGO, July 30, 2026 /PRNewswire/ — Illumina, Inc. (Nasdaq: ILMN) (“Illumina” or the “company”) today announced its financial results for the second quarter of fiscal year 2026. Second quarter 2026 results Revenue of $1.16 billion for Q2 2026, up 9.5% from Q2 2025 and up 8.1%…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
